New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

Bioluminescent luciferase enzymes have historically been too dim to use as probes in living tissue. But recent advances have ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive antibiotic resistance and even shape entire ecosystems. Now an interdisciplinary ...

The University of Hong Kong has patented RNA polymerase β subunit/RNA polymerase sigma factor RpoD (bacterial) interaction inhibitors reported to be useful for the treatment of gram-positive bacterial ...

including 40 samples with a positive molecular diagnosis and 90 negative samples from apparently healthy people for control. They developed benchmarks for expression and splicing using RNA-seq ...

A research team from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, in collaboration with the Helmholtz Centre for Infection Research (HZI) in Braunschweig ...